Charles Schwab’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.32M | Buy |
756,558
+87,602
| +13% | +$379K | ﹤0.01% | 2671 |
|
|
2025
Q4 | $2.38M | Sell |
668,956
-48,422
| -7% | -$297K | ﹤0.01% | 2708 |
|
|
2025
Q3 | $6.38M | Buy |
717,378
+7,762
| +1% | +$78.7K | ﹤0.01% | 2321 |
|
|
2025
Q2 | $6.54M | Buy |
709,616
+39,705
| +6% | +$339K | ﹤0.01% | 2216 |
|
|
2025
Q1 | $5.75M | Sell |
669,911
-7,304
| -1% | -$69K | ﹤0.01% | 2210 |
|
|
2024
Q4 | $7.27M | Buy |
677,215
+11,239
| +2% | +$86.5K | ﹤0.01% | 2156 |
|
|
2024
Q3 | $3.78M | Buy |
665,976
+14,892
| +2% | +$85.9K | ﹤0.01% | 2506 |
|
|
2024
Q2 | $2.75M | Buy |
651,084
+21,017
| +3% | +$85K | ﹤0.01% | 2590 |
|
|
2024
Q1 | $3.21M | Buy |
630,067
+7,757
| +1% | +$43.7K | ﹤0.01% | 2457 |
|
|
2023
Q4 | $5.79M | Buy |
622,310
+17,499
| +3% | +$120K | ﹤0.01% | 2245 |
|
|
2023
Q3 | $3.96M | Buy |
604,811
+23,549
| +4% | +$187K | ﹤0.01% | 2354 |
|
|
2023
Q2 | $4.73M | Buy |
581,262
+21,219
| +4% | +$182K | ﹤0.01% | 2254 |
|
|
2023
Q1 | $4.8M | Sell |
560,043
-5,645
| -1% | -$56.3K | ﹤0.01% | 2220 |
|
|
2022
Q4 | $5.24M | Buy |
565,688
+22,829
| +4% | +$244K | ﹤0.01% | 2195 |
|
|
2022
Q3 | $5.6M | Buy |
542,859
+19,142
| +4% | +$202K | ﹤0.01% | 2155 |
|
|
2022
Q2 | $5.24M | Sell |
523,717
-6,969
| -1% | -$66K | ﹤0.01% | 2169 |
|
|
2022
Q1 | $6.53M | Buy |
530,686
+14,846
| +3% | +$183K | ﹤0.01% | 2159 |
|
|
2021
Q4 | $8.95M | Buy |
515,840
+16,634
| +3% | +$316K | ﹤0.01% | 2057 |
|
|
2021
Q3 | $8.96M | Buy |
499,206
+340,353
| +214% | +$6.77M | ﹤0.01% | 2070 |
|
|
2021
Q2 | $3.63M | Buy |
158,853
+10,214
| +7% | +$151K | ﹤0.01% | 2503 |
|
|
2021
Q1 | $2.22M | Buy |
148,639
+14,189
| +11% | +$155K | ﹤0.01% | 2630 |
|
|
2020
Q4 | $727K | Buy |
134,450
+8,266
| +7% | +$43.6K | ﹤0.01% | 2872 |
|
|
2020
Q3 | $575K | Hold |
126,184
| – | – | ﹤0.01% | 2838 |
|
|
2020
Q2 | $621K | Buy |
126,184
+5,647
| +5% | +$21.3K | ﹤0.01% | 2755 |
|
|
2020
Q1 | $380K | Buy |
120,537
+14,316
| +13% | +$49.9K | ﹤0.01% | 2803 |
|
|
2019
Q4 | $276K | Hold |
106,221
| – | – | ﹤0.01% | 2991 |
|
|
2019
Q3 | $336K | Buy |
106,221
+1,042
| +1% | +$3.01K | ﹤0.01% | 2942 |
|
|
2019
Q2 | $355K | Buy |
105,179
+89,305
| +563% | +$277K | ﹤0.01% | 2962 |
|
|
2019
Q1 | $49K | Buy |
+15,874
| New | +$37.9K | ﹤0.01% | 3131 |
|
|
2018
Q2 | – | Sell |
-76,200
| Closed | -$211K | – | 3116 |
|
|
2018
Q1 | $211K | Buy |
76,200
+25,000
| +49% | +$70.6K | ﹤0.01% | 2976 |
|
|
2017
Q4 | $165K | Hold |
51,200
| – | – | ﹤0.01% | 3009 |
|
|
2017
Q3 | $212K | Hold |
51,200
| – | – | ﹤0.01% | 2994 |
|
|
2017
Q2 | $273K | Hold |
51,200
| – | – | ﹤0.01% | 2903 |
|
|
2017
Q1 | $294K | Hold |
51,200
| – | – | ﹤0.01% | 2827 |
|
|
2016
Q4 | $203K | Hold |
51,200
| – | – | ﹤0.01% | 2962 |
|
|
2016
Q3 | $186K | Hold |
51,200
| – | – | ﹤0.01% | 2930 |
|
|
2016
Q2 | $313K | Buy |
+51,200
| New | +$247K | ﹤0.01% | 2767 |
|
Other funds holding AVXL
VCM
SF
VPM